Jim Simons acquired 3.08 Million Sangamo Therapeutics shares worth $2.16 Million. That's 0.00% of their equity portfolio (1802nd largest holding). The investor owns 1.35% of the outstanding Sangamo Therapeutics stock. The first Sangamo Therapeutics trade was made in Q2 2013. Since then Jim Simons bought shares sixteen more times and sold shares on seventeen occasions. The investor's estimated purchase price is $12 Million, resulting in a loss of 82%.